PPPHealth4All is honored to introduce a member of the PPPHealth4All Advisory Board – Mrs Audrey Mwala, Acting CEO of Malawi PPP Commission, Co-President of AP3Network, Founder of Sycamore Consult Limited.
„It is a great honor for me to join the PPPHealth4All Advisory Board to play a role of making health not a privilege but a basic service available for all. The vision of PPPHealth4All Advisory Board personally speaks to my heart and ignites my zeal and eager to one day step into a world in which everyone can live a long and healthy life. Coming from Africa where over one million babies prematurely die within 4 weeks of birth and 25% die before 5 years it is my sincere desire to see a world where everyone has access to health infrastructure and service enabling them to live long and healthy lives.”
I am very excited to be in the team that is championing this agenda to end preventable deaths of babies, reduce global mortality and end pandemics to attain Agenda 2030 and SDG.3
PPPHealth4All is honored to introduce a member of the PPPHealth4All Advisory Board- Engr Chidi Izuwah, DG /CEO The Presidency Infrastructure Concession Regulatory Commission of Nigeria; Co-President of Africa Public Private Partnership Network; Member of Steering Committee, WAPPP; Co-founder Defeat Autism in Nigeria Advocacy Group.
„ …I wish PPPHealth4All all the best in its quest to promote better healthcare and greater wellbeing of citizens all over the world and in Nigeria in particular through the promotion of innovative, affordable and sustainable PPP health models. PPPHealth4All can help mobilize international support to:
close African healthcare infrastructure gap exposed by current Covid-19 pandemic;
assist African governments in adoption of PPP models to finance healthcare infrastructure with engagement of MDBs;
strengthen the participation of African banks in health PPPs through innovative financing structures.
I look forward to selflessly playing my part as a member of the advisory board to ensure that the health infrastructure and current outcomes in Africa get the urgent intervention required via various innovative PPP models to address communicable and non communicable disease burden in Africa.”
"My dream is to see a better and healthy Africa via the impact of innovative healthcare PPPs."
Government of Assam (India) partnered with the NGO “Centre for North East Studies and Policy Research ” under the NRHM-Public Private Partnership (PPP) to set up a boat-clinic service which is helping to reach the far-flung areas of the state. In these districts, the boat clinics are reaching the poor and marginalized population with sustained health care since last two years. The boat clinics provide both preventive and curative care to the population residing in the islands.
Under this PPP the operational cost and human resource remuneration are borne by the NRHM, Assam whereas the infrastructure meaning construction of the boats is the responsibility of CNES along with the insurance of the boats. The medicines, vaccines and family planning consumables are supplied from District Health Society. Monitoring mechanism: Under this PPP the partner implementing agency submits monthly action plan and physical & financial progress report to the State. Besides the regular reporting system quarterly review meeting were performed to understand the progress and difficulties arises while implementing the programme.
Progress achieved: The response to the service being provided by the boat clinics for the marginalized population is overwhelming as the community was deprived from the basic health services due to non availability of the health infrastructure. Before the NRHM-PPP these island dwellers had a rare chance to visit health personnel and seek treatment for their illness. A total of 2,08,203 general health checkups were done and 8,109 pregnant women received the ante-natal checkups, 2,002 women receives post-natal follow-up and 15,818 children were immunized.
Through the Mental Health & Suicide Prevention National Response to COVID-19 (National Response), diverse partners are bringing their best in science, innovation, and leadership to create sustainable and comprehensive solutions to the mental health impacts of this pandemic.
As a national convener, the National Action Alliance for Suicide Prevention (Action Alliance)—the US nation’s public-private partnership—is mobilizing diverse sectors to collectively lead a coordinated mental health and suicide prevention response effort during and in the aftermath of COVID-19.
The National Institutes of Health and the Foundation for the NIH (FNIH) are bringing together more than a dozen leading biopharmaceutical companies, the Health and Human Services Office of the Assistant Secretary for Preparedness and Response, the Centers for Disease Control and Prevention, the U.S. Food and Drug Administration and the European Medicines Agency to develop an international strategy for a coordinated research response to the COVID-19 pandemic. The planned Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) partnership will develop a collaborative framework for prioritizing vaccine and drug candidates, streamlining clinical trials, coordinating regulatory processes and/or leveraging assets among all partners to rapidly respond to the COVID-19 and future pandemics.
Coordinated by the FNIH, ACTIV government and industry partners will provide infrastructure, subject matter expertise and/or funding (both new and in-kind) to identify, prioritize and facilitate the entry of some of the most promising candidates into clinical trials. Industry partners also will make available certain prioritized compounds, some of which have already cleared various phases of development, and associated data to support research related to COVID-19.
ACTIV will have four fast-track focus areas:
Standardize and share preclinical evaluation methods in an open forum that allows for comparison and validation by:
Prioritize and accelerate clinical evaluation of therapeutic candidates with near-term potential by:
Maximize clinical trial capacity and effectiveness by:
Advance vaccine development
“This powerful public-private partnership will focus and expedite R&D activities required to combat COVID-19,” says Maria C. Freire, Ph.D., President and Executive Director, FNIH. “Working in lock-step, the public and private sectors will maximize the chances of success and provide a roadmap to pre-emptively manage future threats.”
This webinar is led by the World Association of PPP Units and Professionals (WAPPP), addressing the impact of the Covid-19 pandemic upon Public-Private Partnerships projects and programs. Hear the presentation and audience questions posed to our PPP experts. During this webinar, the panellists discuss the impact of the COVID-19 Pandemic on PPP projects and programs, how to deal with its repercussions, lessons learned and opportunities that might come out of it. During this webinar learn more about:
The impact of Covid-19 on the preparation and delivery of PPP Projects and Programs
The impact of Covid-19 on the CP3P training and certification program
The measures that are being taken to minimise the impact of Covid-19
The opportunity to ask questions of a panel of PPP professionals and propose suggestions to minimise the impact.
David Baxter, International Development Consultant, PPP Navigator
In the past few months, the global COVID-19 pandemic has drastically changed our society, and has impacted humanity on individual, economic, and social levels. All countries have been affected by this crisis and are starting to band together in order to fight the spread of thisdisease and minimize its devastating effects.
We would like to investigate how public -private partnerships could be applied in mitigation of COVID-19 and to collect use cases that could inspire the national goverments to pursue public-private partnership model. Known examples could could be found here.
Our aim is to demonstrate solidarity within the EU on COVID-19. We propose to develop anon-line platform „COVID-19 Smart Response“ to provide non-public actors in the EU with tools and instruments to share related know-how and resources for mitigation of COVID-19 crisis.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.